GeoVax Labs

GeoVax Labs GOVX Stock

$1.81   -5.235603%
Add to favorites
Market Cap
$985.46K
LOW - HIGH [24H]
$1.75 - $1.95
VOLUME [24H]
$3.74M
P/E Ratio
0
Earnings per share
-$15.02
ISIN
US3736786068
Price   Prediction

GeoVax Labs Price Chart

Sorry, that's all we've gotfor now...

GeoVax Labs (GOVX) stock price today is 1.81 USD on Tech Market Small (-5.24% on the day). Updated .

GeoVax Labs GOVX Financial and Trading Overview

GeoVax Labs stock price 1.81 USD
Previous Close 1.91 USD
Open 1.85 USD
Bid 0.25 USD x 600
Ask 1.9 USD x 100
Day's Range 1.75 - 1.95 USD
52 Week Range 1.51 - 270.6 USD
Volume 3.74M USD
Avg. Volume 213.41K USD
Market Cap 985.46K USD
Beta (5Y Monthly) 3.86
PE Ratio (TTM) N/A
EPS (TTM) -15.03 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 240 USD

GOVX Valuation Measures

Enterprise Value -915033 USD
Trailing P/E N/A
Forward P/E -2.104651
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)
Price/Book (mrq) 0.6639765
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.05

Trading Information

GeoVax Labs Stock Price History

Beta (5Y Monthly) 3.86
52-Week Change -99.20%
S&P500 52-Week Change 3.06%
52 Week High 270.6 USD
52 Week Low 1.51 USD
50-Day Moving Average 5.76 USD
200-Day Moving Average 25.27 USD

GOVX Share Statistics

Avg. Volume (3 month) 213.41K USD
Avg. Daily Volume (10-Days) 1.21M USD
Shares Outstanding 544.45K
Float 511.46K
Short Ratio 0.21
% Held by Insiders 0.021%
% Held by Institutions 3.91%
Shares Short 7.33K
Short % of Float 1.73%
Short % of Shares Outstanding 1.73%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:24

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -225.62%
Return on Equity (ttm) -603.26%

Income Statement

Revenue (ttm) 0 USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -12828081 USD
EBITDA -18280254 USD
Net Income Avi to Common (ttm) -18262924 USD
Diluted EPS (ttm) -15.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 2.15M USD
Total Cash Per Share (mrq) 3.95 USD
Total Debt (mrq) 250.45K USD
Total Debt/Equity (mrq) 21.83 USD
Current Ratio (mrq) 1.458
Book Value Per Share (mrq) 2.726

Cash Flow Statement

Operating Cash Flow (ttm) -16498304 USD
Levered Free Cash Flow (ttm) -9801717 USD

Profile of GeoVax Labs

Country United States
State GA
City Smyrna
Address 1955 Lake Park Drive
ZIP 30080
Phone 678 384 7220
Website https://www.geovax.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 19

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Q&A For GeoVax Labs Stock

What is a current GOVX stock price?

GeoVax Labs GOVX stock price today per share is 1.81 USD.

How to purchase GeoVax Labs stock?

You can buy GOVX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for GeoVax Labs?

The stock symbol or ticker of GeoVax Labs is GOVX.

Which industry does the GeoVax Labs company belong to?

The GeoVax Labs industry is Biotechnology.

How many shares does GeoVax Labs have in circulation?

The max supply of GeoVax Labs shares is 544.45K.

What is GeoVax Labs Price to Earnings Ratio (PE Ratio)?

GeoVax Labs PE Ratio is now.

What was GeoVax Labs earnings per share over the trailing 12 months (TTM)?

GeoVax Labs EPS is -15.03 USD over the trailing 12 months.

Which sector does the GeoVax Labs company belong to?

The GeoVax Labs sector is Healthcare.

GeoVax Labs GOVX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
$2.05T
Total marketcap
$79.87B
Total volume
BTC 57.68%   •   ETH 9.85%
Dominance
Select currency